AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 73 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,509 | -2.1% | 1,935 | 0.0% | 0.00% | – |
| Q2 2023 | $4,605 | +29.4% | 1,935 | 0.0% | 0.00% | – |
| Q1 2023 | $3,560 | -3.2% | 1,935 | 0.0% | 0.00% | – |
| Q4 2022 | $3,677 | +267.7% | 1,935 | +993.2% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 177 | -55.0% | 0.00% | – |
| Q1 2022 | $2,000 | -75.0% | 393 | -75.5% | 0.00% | -100.0% |
| Q4 2021 | $8,000 | -69.2% | 1,602 | -59.1% | 0.00% | -85.7% |
| Q3 2021 | $26,000 | -50.0% | 3,916 | -50.3% | 0.01% | -41.7% |
| Q2 2021 | $52,000 | +205.9% | 7,882 | +162.7% | 0.01% | +200.0% |
| Q1 2021 | $17,000 | +240.0% | 3,000 | +394.2% | 0.00% | +300.0% |
| Q4 2020 | $5,000 | -16.7% | 607 | +22.6% | 0.00% | -50.0% |
| Q3 2020 | $6,000 | -25.0% | 495 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $8,000 | +100.0% | 495 | -19.6% | 0.00% | 0.0% |
| Q1 2020 | $4,000 | – | 616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
| Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
| MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
| Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
| Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
| Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
| Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
| Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |